Short term use of oral benzodiazepines, BZDs, for periprocedural anxiolysis seems to be safe and effective. The 2020 FDA black-box warning should not deter their appropriate use in dermatologic surgery and other low-risk outpatient procedures, says recent research from Ohio State University.
- Read more about Short term use of oral BZDs for periprocedural anxiolysis is safe, says research
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/short-term-use-of-oral-BZDs-for-periprocedural-anxiolysis-is-safe-says-research
No comments:
Post a Comment